Several authors reported that TLR4 activation promoted the production of immunosuppressive and proangiogenic cytokines by tumor cells, including IL-10, IL-8, TGF-β, and vascular endothelial growth factor [91,96,97]. This evidence concerns the gene TLR4 and neoplasm.